Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Kedudukan dalam Saham
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Harga Saham
$8.03
Modal Pasaran
$6.31B
Perubahan (1 hari)
1.07%
Perubahan (1 tahun)
-8.04%
Negara
CN
Perdagangan Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Kategori
Healthcare
Nisbah P/B bagi Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Nisbah P/B pada October 2026 TTM: 4.68
Menurut laporan kewangan dan harga saham terkini Shenzhen New Industries Biomedical Engineering Co., Ltd., nisbah P/B semasa (TTM) ialah 4.68. Pada akhir 2024, nisbah P/B syarikat ialah 6.49.
Sejarah nisbah P/B untuk Shenzhen New Industries Biomedical Engineering Co., Ltd. dari 2012 hingga 2026
Nisbah P/B pada akhir setiap tahun
| Tahun | Nisbah P/B | Ubah |
|---|---|---|
| 2026 (TTM) | 4.68 | -3.03% |
| 2025 | 4.83 | -25.54% |
| 2024 | 6.49 | -20.27% |
| 2023 | 8.14 | 32.24% |
| 2022 | 6.16 | 0.04% |
| 2021 | 6.15 | -45.62% |
| 2020 | 11.32 | 90.90% |
| 2019 | 5.93 | -16.23% |
| 2018 | 7.08 | -25.11% |
| 2017 | 9.45 | -19.91% |
| 2016 | 11.80 | -26.76% |
| 2015 | 16.11 | -39.63% |
| 2014 | 26.68 | -37.95% |
| 2013 | 43.00 | -34.49% |
| 2012 | 65.64 | 0.00% |
Nisbah P/B untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/B | Perbezaan Nisbah P/B | Negara |
|---|---|---|---|
| 3.4297 | -26.78% |
US
|
|
| 2.4161 | -48.42% |
IE
|
|
| 4.9278 | 5.21% |
US
|
|
| 2.6381 | -43.68% |
US
|
|
| 2.4467 | -47.76% |
DE
|